DEC 30, 2016 1:47 PM PST

Male Contraception Candidate Drug may Also Shrink Testicular Tumor


An experimental drug that was originally intended to work for male contraception may also work to shrink testicular cancer.

The drug is a small-molecule inhibitor by the name of JQ1. Instead of working to influence changes at the DNA level, JQ1 affects changes at the epigenetic level. In particular, this drug interferes with protein binding at the bromodomain - a stretch of amino acids that “reads” certain chemical tags on histones.

"JQ1 inhibits those proteins that read these histone marks and thus changes the gene activity in the cell," explained Hubert Schorle from the Institute for Pathology at the University of Bonn, and the study’s senior author.

Previously, researchers showed that JQ1 inhibited an essential part of sperm development. Treatment of this drug in mice led to smaller testes, sperm count and motility. As such, it was considered for the part of a male contraceptive drug.

In studying the mechanisms of JQ1’s actions, researcher at the University of Bonn realized that the molecule could also influence testicular cancer development. JQ1 appears to inhibit bromodomain and extraterminal (BET) proteins, which in testicular cancer, triggers cellular stress signals and cause the cell to die.

"In a testicular cancer mouse model, the tumors began to shrink after administering JQ1," said Sina Jostes, the study’s lead author. "In contrast, healthy skin cells seem to tolerate JQ1 very well." The team showed positive tumor shrinkage in both cell culture and live animal models.

Jostes and colleagues also tested the effects of JQ1 alongside another histone deacetylase inhibitor known as romidepsin. This drug has previously been tested and approved for testicular cancer. However, the team reported that the combination of JQ1 and romidepsin seemed to have the greatest effect, especially in cancer types that proved resistant to therapy.

"In our study, we treated mice with both JQ1 and romidepsin," said Daniel Nettersheim, the study’s co-author. "This way, we achieved a similar effect alike JQ1 or romidepsin treatment alone, but we could reduce the quantities of both substances. Such a combination therapy to treat testicular tumors may be much better tolerated. Chemotherapy-resistant patients could also benefit from this."

Both the anticancer effects and the contraceptive effects of JQ1 are under further investigation.

Additional source:  University of Bonn

About the Author
Bachelor's (BA/BS/Other)
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at
You May Also Like
OCT 31, 2022
Pumpkins: A Trick or a Treat for Cancer?
Pumpkins: A Trick or a Treat for Cancer?
Cancer is a disease that impacts the whole person, wreaking havoc on an individual’s emotional and physical well-b ...
NOV 02, 2022
Genetics & Genomics
Want to advance your miRNA research?
Want to advance your miRNA research?
miRNAs as potential biomarkers MicroRNAs (miRNAs) are non-coding RNAs, 18-26 nucleotides long. They play an important ro ...
DEC 21, 2022
The Next Generation of Flow Cytometry Controls
The Next Generation of Flow Cytometry Controls
If you work in cell biology or immunology, chances are that you're familiar with flow cytometry. This technique meas ...
NOV 29, 2022
Drug Discovery & Development
Kicking Pro-tumor Immune Cells Out of the Microenvironment
Kicking Pro-tumor Immune Cells Out of the Microenvironment
Tumors use our own immune systems against us by coaxing regulatory T cells to keep antitumor immune response low. But re ...
DEC 22, 2022
Handheld Device for Detecting Oral Cancer
Handheld Device for Detecting Oral Cancer
According the that National Cancer Institute, cancers of the oral cavity and pharynx are expected to have accounted for ...
JAN 12, 2023
Can Abnormalities in Blood Cells Lead to Lung Cancer?
Can Abnormalities in Blood Cells Lead to Lung Cancer?
Hematopoiesis, a biological process resulting in the formation of new blood cells, occurs throughout our lifetime.  ...
Loading Comments...